Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Goodwill (2023 - 2024)

Historic Goodwill for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q4 2024 value amounting to $2.0 million.

  • Indivior Pharmaceuticals' Goodwill fell 6000.0% to $2.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.0 million, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of $2.0 million for FY2024, which is 6000.0% down from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Goodwill of $2.0 million as of Q4 2024, which was down 6000.0% from $2.0 million recorded in Q3 2024.
  • In the past 5 years, Indivior Pharmaceuticals' Goodwill registered a high of $5.0 million during Q4 2023, and its lowest value of $2.0 million during Q1 2024.